GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xeris Biopharma Holdings Inc (LTS:0A8E) » Definitions » Accounts Payable

Xeris Biopharma Holdings (LTS:0A8E) Accounts Payable : $2.3 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Xeris Biopharma Holdings Accounts Payable?

Xeris Biopharma Holdings's Accounts Payable for the quarter that ended in Dec. 2024 was $2.3 Mil.

Xeris Biopharma Holdings's quarterly Accounts Payable increased from Jun. 2024 ($5.8 Mil) to Sep. 2024 ($7.5 Mil) but then declined from Sep. 2024 ($7.5 Mil) to Dec. 2024 ($2.3 Mil).

Xeris Biopharma Holdings's annual Accounts Payable increased from Dec. 2022 ($4.6 Mil) to Dec. 2023 ($11.6 Mil) but then declined from Dec. 2023 ($11.6 Mil) to Dec. 2024 ($2.3 Mil).


Xeris Biopharma Holdings Accounts Payable Historical Data

The historical data trend for Xeris Biopharma Holdings's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xeris Biopharma Holdings Accounts Payable Chart

Xeris Biopharma Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 3.12 8.92 4.61 11.57 2.29

Xeris Biopharma Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.57 7.09 5.80 7.45 2.29

Xeris Biopharma Holdings Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Xeris Biopharma Holdings Accounts Payable Related Terms

Thank you for viewing the detailed overview of Xeris Biopharma Holdings's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Xeris Biopharma Holdings Business Description

Traded in Other Exchanges
Address
1375 West Fulton Street, Suite 1300, Chicago, IL, USA, 60607
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Xeris Biopharma Holdings Headlines

No Headlines